118 related articles for article (PubMed ID: 12089922)
21. Pulse oral versus pulse intraperitoneal calcitriol: a comparison of efficacy in the treatment of hyperparathyroidism and renal osteodystrophy in peritoneal dialysis patients.
Gadallah MF; Arora N; Torres C; Ramdeen G; Schaeffer-Pautz A; Moles K
Adv Perit Dial; 2000; 16():303-7. PubMed ID: 11045316
[TBL] [Abstract][Full Text] [Related]
22. [Changes of PTH, 1,25(OH)2D3 and biochemistry in renal osteodystrophy].
Jia JK; Lou DX; Zhu P
Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):33-6. PubMed ID: 8045186
[TBL] [Abstract][Full Text] [Related]
23. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry.
Lehmann G; Stein G; Hüller M; Schemer R; Ramakrishnan K; Goodman WG
Kidney Int; 2005 Sep; 68(3):1206-14. PubMed ID: 16105052
[TBL] [Abstract][Full Text] [Related]
24. Surgically induced uremia in rats. I: Effect on bone strength and metabolism.
Jablonski G; Klem KH; Attramadal A; Dahl E; Rønningen H; Gautvik KM; Haug E; Gordeladze JO
Biosci Rep; 1993 Oct; 13(5):275-87. PubMed ID: 8142613
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
[TBL] [Abstract][Full Text] [Related]
26. [Ultrasonography methods in the diagnosis of renal osteodystrophy].
Tomić-Brzac H; Pavlović D
Acta Med Croatica; 2004; 58(1):43-9. PubMed ID: 15125393
[TBL] [Abstract][Full Text] [Related]
27. Can bone histomorphometry be predicted by clinical assessment and noninvasive techniques in peritoneal dialysis?
Joffe P; Heaf JG; Jensen C
Miner Electrolyte Metab; 1996; 22(4):224-33. PubMed ID: 8807626
[TBL] [Abstract][Full Text] [Related]
28. Bone disease in renal failure. Clinical and histomorphometric studies.
Nilsson P
Scand J Urol Nephrol Suppl; 1984; 84():1-68. PubMed ID: 6393322
[TBL] [Abstract][Full Text] [Related]
29. Bone disease in patients with long-term renal transplantation and normal renal function.
Carlini RG; Rojas E; Weisinger JR; Lopez M; Martinis R; Arminio A; Bellorin-Font E
Am J Kidney Dis; 2000 Jul; 36(1):160-6. PubMed ID: 10873886
[TBL] [Abstract][Full Text] [Related]
30. Renal osteodystrophy.
Coburn JW; Henry DA
Adv Intern Med; 1984; 30():387-424. PubMed ID: 6397042
[TBL] [Abstract][Full Text] [Related]
31. Effect of CAPD and hemodialysis on parathyroid function.
Malberti F; Corradi B; Imbasciati E
Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
[TBL] [Abstract][Full Text] [Related]
32. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
33. [Markers of calcium--phosphate metabolism and bones alterations in long term kidney transplant patients].
Spiechowicz U; Kokot F; Wiecek A
Przegl Lek; 2003; 60(11):690-4. PubMed ID: 15058034
[TBL] [Abstract][Full Text] [Related]
34. Renal ostodystrophy during the developing stage of maintenance dialysis in Transylvania. Early development of periarticular calcifications and beta 2 microglobulin amyloidosis in spite of a relatively good prevention of secondary hyperparathyroidism.
Oprisiu R; Bolosiu H; Boca I; Theodoru C; Elefterescu R; Brazier M; el Esper I; Leflon P; Ledeme C; Fournier A; Heinze V
Ann Med Interne (Paris); 1998 Mar; 149(2):67-75. PubMed ID: 11490527
[TBL] [Abstract][Full Text] [Related]
35. Renal osteodystrophy: review of the disease and its treatment.
El-Kishawi AM; El-Nahas AM
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):373-82. PubMed ID: 16970258
[TBL] [Abstract][Full Text] [Related]
36. [Serum beta-type I collagen carboxyterminal telopeptide (beta-CTXs) and bone involvement in chronic renal failure].
Oliveri B; Wittich AC; Nadal MA; Zeni SN
Medicina (B Aires); 2005; 65(4):321-8. PubMed ID: 16193710
[TBL] [Abstract][Full Text] [Related]
37. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic value of PTH total kit for estimation of bone turnover in children with chronic renal failure].
Ziółkowska H; Roszkowska-Blaim M
Przegl Lek; 2006; 63 Suppl 3():149-52. PubMed ID: 16898516
[TBL] [Abstract][Full Text] [Related]
39. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy.
Andress DL; Endres DB; Maloney NA; Kopp JB; Coburn JW; Sherrard DJ
J Clin Endocrinol Metab; 1986 Nov; 63(5):1163-9. PubMed ID: 3760116
[TBL] [Abstract][Full Text] [Related]
40. [PTH and bone metabolism in chronic dialysis patients].
Fukagawa M; Kazama J; Shigematsu T
Rinsho Byori; 2001 Mar; 49(3):236-8. PubMed ID: 11307321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
